| Age at LT | Gender | Ethnicity | LT year | Type of serologic conversion | Conversion year (from LT) | Post-LT HCV treatment | Treatment year post-LT | Treatment medication |
---|---|---|---|---|---|---|---|---|---|
Pt 1 | 46 | Male | Caucasian | 1998 | IgM | 5 | Yes | 1-5 | IFN + RBV |
Pt 2 | 48 | Male | Caucasian | 1998 | IgG | 1 | Yes | 0-1 | IFN + RBV |
Pt 3 | 39 | Male | Native Hawaiian | 2000 | IgG | 5 | Yes | 2-3 | IFN + RBV |
Pt 4 | 36 | Female | Caucasian | 2001 | IgG | 1 | Yes | 0-1 | IFN + RBV |
Pt 5 | 47 | Male | Other NS | 2001 | IgG | 1 | Yes | 0 | IFN |
Pt 6 | 51 | Male | Caucasian | 2001 | IgG | 5 | Yes | 2-4 | IFN + RBV |
Pt 7 | 47 | Male | Caucasian | 2003 | IgG | 3 | Yes | 1-4 | IFN + RBV |
Pt 8 | 51 | Male | Caucasian | 2004 | IgG | 5 | Yes | 0-3 | IFN + RBV |
Pt 9 | 54 | Male | Caucasian | 2009 | IgG | 1 | No | N/A | N/A |